Halozyme Therapeutics | HALO - PE Price to Earnings

Stock Price
80.82
Daily Change
2.40 3.06%
Monthly
7.60%
Yearly
41.54%
Q1 Forecast
69.50

Halozyme Therapeutics reported $15.46 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
Agios Pharmaceuticals USD 2.88 0.36 Jun/2025
Amarin USD 91.05 88.3 Jun/2023
Amgen USD 9.49 3.02 Sep/2025
Baxter International USD 17.1 4.46 Sep/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Halozyme Therapeutics USD 15.46 3.56 Sep/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
MannKind USD 30.56 6.84 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
United Therapeutics USD 15.7 4.24 Sep/2025